CR9270A - Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales - Google Patents

Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales

Info

Publication number
CR9270A
CR9270A CR9270A CR9270A CR9270A CR 9270 A CR9270 A CR 9270A CR 9270 A CR9270 A CR 9270A CR 9270 A CR9270 A CR 9270A CR 9270 A CR9270 A CR 9270A
Authority
CR
Costa Rica
Prior art keywords
prevention
preparation
treatment
renal diseases
useful medicines
Prior art date
Application number
CR9270A
Other languages
English (en)
Inventor
Bensaid Mohammed
Janiak Philip
Marc Herbert Jean
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0501919A external-priority patent/FR2882262B1/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR9270A publication Critical patent/CR9270A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilizacion de un compuesto antagonista de los receptores CB1 DE CANNABINOIDES, a solas o asociado con otro principio activo, derivado del pirazol, para la preparacion de medicamentos utiles en la prevencion y el tratamiento de las enfermadades renales
CR9270A 2005-02-23 2007-07-20 Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales CR9270A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501919A FR2882262B1 (fr) 2005-02-23 2005-02-23 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR0504798A FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Publications (1)

Publication Number Publication Date
CR9270A true CR9270A (es) 2007-10-01

Family

ID=36603585

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9270A CR9270A (es) 2005-02-23 2007-07-20 Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales

Country Status (18)

Country Link
US (1) US7622488B2 (es)
EP (1) EP1855675A1 (es)
JP (1) JP2008531526A (es)
KR (1) KR20070104916A (es)
AR (1) AR054003A1 (es)
AU (1) AU2006217794A1 (es)
BR (1) BRPI0607894A2 (es)
CA (1) CA2597802A1 (es)
CR (1) CR9270A (es)
EA (1) EA011655B1 (es)
FR (1) FR2882263B1 (es)
IL (1) IL185165A0 (es)
MA (1) MA29263B1 (es)
MX (1) MX2007009995A (es)
NO (1) NO20074768L (es)
TN (1) TNSN07291A1 (es)
TW (1) TW200640458A (es)
WO (1) WO2006090047A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
AR051446A1 (es) * 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)

Also Published As

Publication number Publication date
NO20074768L (no) 2007-11-23
FR2882263A1 (fr) 2006-08-25
JP2008531526A (ja) 2008-08-14
MX2007009995A (es) 2007-10-10
TW200640458A (en) 2006-12-01
EA200701800A1 (ru) 2008-02-28
US20080015228A1 (en) 2008-01-17
AU2006217794A1 (en) 2006-08-31
MA29263B1 (fr) 2008-02-01
EA011655B1 (ru) 2009-04-28
IL185165A0 (en) 2008-06-05
CA2597802A1 (fr) 2006-08-31
US7622488B2 (en) 2009-11-24
BRPI0607894A2 (pt) 2009-10-20
EP1855675A1 (fr) 2007-11-21
WO2006090047A1 (fr) 2006-08-31
TNSN07291A1 (en) 2008-12-31
FR2882263B1 (fr) 2007-04-06
KR20070104916A (ko) 2007-10-29
AR054003A1 (es) 2007-05-30

Similar Documents

Publication Publication Date Title
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
AR063550A2 (es) Utilizacion de un derivado de pirazol para la preparcion de medicamentos utiles para la prevencion y eltratamiento de la displidemias y de las enefermedades asociadas a las dislipidemias y/o a la obesidad
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
CL2007000601A1 (es) Compuestos derivados de heterobiciclos pirazolicos, inhibidores de la actividad de proteina tiroxina quinasa; composicion farmaceutica que comprende dichos compuestos; y uso de los compuestos en el tratamiento de una enfermedad hiperproliferativa.
UY28955A1 (es) Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos
ES2422557T3 (es) Compuestos y composiciones como moduladores de la ruta Hedgehog
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
EA201000784A1 (ru) Антагонисты пути hedgehog и их терапевтические применения
NO20083630L (no) Nye pyridinderivater
DE602008004356D1 (de) Konservierungsmittelfreie augenlösung auf prostaglandin-basis
BRPI0516570A (pt) combinação de substáncias ativas fungicidas
CL2008002242A1 (es) Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos.
CR11264A (es) Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa
NO20091299L (no) Substituerte sulfonamidderivater
MX2009006567A (es) Pirimidinilpirazoles como principios activos insecticidas y parasiticidas.
MX2010001574A (es) Ligandos del receptor cannabinoide.
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
EA201070689A1 (ru) Композиция для личного ухода
CR11057A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
BRPI0608287A2 (pt) agente endoparasiticida
CR10029A (es) Combinacion de productos activos fungicidas
DOP2010000197A (es) Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
PH12019500327A1 (en) Indazole compounds for use in tendon and/or ligament injuries

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)